Biomarkers in t-cell therapy trials

Immunotherapy and personalised medicine in review

2015 ecancermedicalscience Journal Report

New strategies for ms-based metabolomics

Polycystic kidney disease: Identifying a pathogenic pathway

The occurrence of septic shock: difficulty in predicting the outcomes

Mass spectrometry: a key metabolomics platform in metabolic diseases

Pharmametabolomics and the integration of metabolomics in drug discovery

How can metabolomics help in clinical diagnosis?

Revisiting intrathecal therapy for childhood medulloblastoma

Delivering drugs to CNS tumours: techniques and challenges

Molecular drug imaging to guide brain cancer therapy